BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed ANAB catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:8946f5a6563b86f9d7dc@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261212
DTEND;VALUE=DATE:20261213
SUMMARY:ANAB PDUFA (company-disclosed): imsidolimab
DESCRIPTION:PDUFA Dec. 12\, 2026 - ANAPTYSBIO\, INC (imsidolimab)\nConfiden
 ce: company-disclosed\nTicker ANAB (confidence 1.0)\nSource: https://www.s
 ec.gov/Archives/edgar/data/1370053/000119312526396690/anab-ex99_1.htm\nSch
 eduling/reference data from public records\; dates can move. Not investmen
 t\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://www.sec.gov/Archives/edgar/data/1370053/000119312526396690/anab
 -ex99_1.htm
CATEGORIES:pdufa,company-disclosed
END:VEVENT
BEGIN:VEVENT
UID:4e83bcab93085d3c5335@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20270201
DTEND;VALUE=DATE:20270202
SUMMARY:ANAB PDUFA (company-disclosed): PDUFA February 2027 - ANAPTYSBIO\, 
 INC
DESCRIPTION:PDUFA February 2027 - ANAPTYSBIO\, INC\nConfidence: company-dis
 closed\nDate precision: month (shown on the first day)\nTicker ANAB (confi
 dence 1.0)\nSource: https://www.sec.gov/Archives/edgar/data/1370053/000119
 312526396690/anab-ex99_1.htm\nScheduling/reference data from public record
 s\; dates can move. Not investment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://www.sec.gov/Archives/edgar/data/1370053/000119312526396690/anab
 -ex99_1.htm
CATEGORIES:pdufa,company-disclosed
END:VEVENT
END:VCALENDAR
